Crocs (CROX) Tops Q4 EPS by 8c, Q1 Revenue Guidance Misses
Get Alerts CROX Hot Sheet
Price: $130.61 --0%
Financial Fact:
Restructuring charges (Note 12): 0
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Restructuring charges (Note 12): 0
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Crocs (NASDAQ: CROX) reported Q4 EPS of ($0.22), $0.08 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $206 million versus the consensus estimate of $204.1 million.
Crocs sees FY2015 revenue of $260-265 million, versus the consensus of $292.17 million.
- "We expect the declines to moderate substantially in Q2 and growth to return in the second half of 2015 as many of the strategic changes we implemented in late 2014 positively impact the business."
For earnings history and earnings-related data on Crocs (CROX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
- POET Technologies Inc. (POET) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share